| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.063 | 0.03 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.04 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.04 |